Isolation and characterization of a new naturally immortalized human breast carcinoma cell line, KAIMRC1

[1]  R. Shirkoohi,et al.  BIRC5 Genomic Copy Number Variation in Early-Onset Breast Cancer , 2016, Iranian biomedical journal.

[2]  Zhijie Kang,et al.  CD47 Promotes Tumor Invasion and Metastasis in Non-small Cell Lung Cancer , 2016, Scientific Reports.

[3]  J. Ahn,et al.  Gene Expression Profiling of Breast Cancer Brain Metastasis , 2016, Scientific Reports.

[4]  G. Semenza,et al.  HIF-1 regulates CD47 expression in breast cancer cells to promote evasion of phagocytosis and maintenance of cancer stem cells , 2015, Proceedings of the National Academy of Sciences.

[5]  K. Coombes,et al.  Phosphorylation of GSK3α/β correlates with activation of AKT and is prognostic for poor overall survival in acute myeloid leukemia patients , 2015, BBA clinical.

[6]  K. Zen,et al.  Loss of Cell Surface CD47 Clustering Formation and Binding Avidity to SIRPα Facilitate Apoptotic Cell Clearance by Macrophages , 2015, The Journal of Immunology.

[7]  D. Wei,et al.  Concise Review: Emerging Role of CD44 in Cancer Stem Cells: A Promising Biomarker and Therapeutic Target , 2015, Stem cells translational medicine.

[8]  M. Diederich,et al.  Early downregulation of Mcl-1 regulates apoptosis triggered by cardiac glycoside UNBS1450 , 2015, Cell Death and Disease.

[9]  Xin Lu,et al.  MCL-1 Is a Key Determinant of Breast Cancer Cell Survival: Validation of MCL-1 Dependency Utilizing a Highly Selective Small Molecule Inhibitor , 2015, Molecular Cancer Therapeutics.

[10]  Nawwaf S. Basakran.  CD44 as a potential diagnostic tumor marker , 2015, Saudi medical journal.

[11]  J. Makki,et al.  Diversity of Breast Carcinoma: Histological Subtypes and Clinical Relevance , 2015, Clinical medicine insights. Pathology.

[12]  D. Nguyen,et al.  Significance of glioma-associated oncogene homolog 1 (GLI1)expression in claudin-low breast cancer and crosstalk with the nuclear factor kappa-light-chain-enhancer of activated B cells (NFκB) pathway , 2014, Breast Cancer Research.

[13]  P. Lu,et al.  Blockade of CD47‐mediated cathepsin S/protease‐activated receptor 2 signaling provides a therapeutic target for hepatocellular carcinoma , 2014, Hepatology.

[14]  A. Voigt,et al.  Immune escape and survival mechanisms in circulating tumor cells of colorectal cancer. , 2014, Cancer research.

[15]  M. Kumar,et al.  Establishment and characterization of two primary breast cancer cell lines from young Indian breast cancer patients: mutation analysis , 2014, Cancer Cell International.

[16]  I. Ellis,et al.  Characteristics of basal cytokeratin expression in breast cancer , 2013, Breast Cancer Research and Treatment.

[17]  D. Roses,et al.  Multiple Breast Cancer Cell-Lines Derived from a Single Tumor Differ in Their Molecular Characteristics and Tumorigenic Potential , 2013, PloS one.

[18]  Joana Paredes,et al.  Cancer stem cells markers CD44, CD24 and ALDH1 in breast cancer special histological types , 2012, Journal of Clinical Pathology.

[19]  S. Fuqua,et al.  The Role of Androgen Receptor in Breast Cancer. , 2012, Drug discovery today. Disease mechanisms.

[20]  Andrew H. Beck,et al.  Antibody therapy targeting the CD47 protein is effective in a model of aggressive metastatic leiomyosarcoma , 2012, Proceedings of the National Academy of Sciences.

[21]  M. Ringnér,et al.  CD44 isoforms are heterogeneously expressed in breast cancer and correlate with tumor subtypes and cancer stem cell markers , 2011, BMC Cancer.

[22]  V. Patil,et al.  E-Cadherin as a diagnostic biomarker in breast cancer , 2011, North American journal of medical sciences.

[23]  Ash A. Alizadeh,et al.  Therapeutic antibody targeting of CD47 eliminates human acute lymphoblastic leukemia. , 2011, Cancer research.

[24]  Patrick W. Lee,et al.  Aldehyde Dehydrogenase Activity of Breast Cancer Stem Cells Is Primarily Due To Isoform ALDH1A3 and Its Expression Is Predictive of Metastasis , 2011, Stem cells.

[25]  S. Varambally,et al.  The neuronal repellent SLIT2 is a target for repression by EZH2 in prostate cancer , 2010, Oncogene.

[26]  Edward J Oakeley,et al.  WNT signaling enhances breast cancer cell motility and blockade of the WNT pathway by sFRP1 suppresses MDA-MB-231 xenograft growth , 2009, Breast Cancer Research.

[27]  Meijia Gu,et al.  Cancer Cell International Establishment and Characterization of Three New Human Breast Cancer Cell Lines Derived from Chinese Breast Cancer Tissues , 2022 .

[28]  Donald E Ingber,et al.  Can cancer be reversed by engineering the tumor microenvironment? , 2008, Seminars in cancer biology.

[29]  Daniel Birnbaum,et al.  ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome. , 2007, Cell stem cell.

[30]  Dung-Fang Lee,et al.  Myeloid cell leukemia-1 inversely correlates with glycogen synthase kinase-3beta activity and associates with poor prognosis in human breast cancer. , 2007, Cancer research.

[31]  Wen-Lin Kuo,et al.  A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes. , 2006, Cancer cell.

[32]  C. Gladson,et al.  New concepts regarding focal adhesion kinase promotion of cell migration and proliferation , 2006, Journal of cellular biochemistry.

[33]  Yoshio Miki,et al.  Role of BRCA1 and BRCA2 as regulators of DNA repair, transcription, and cell cycle in response to DNA damage , 2004, Cancer science.

[34]  Joachim Wegener,et al.  Electrical wound-healing assay for cells in vitro. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[35]  S. Morrison,et al.  Prospective identification of tumorigenic breast cancer cells , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[36]  Z. Werb,et al.  New functions for the matrix metalloproteinases in cancer progression , 2002, Nature Reviews Cancer.

[37]  M. Widschwendter,et al.  Epigenetic Downregulation of the Retinoic Acid Receptor-β2 Gene in Breast Cancer , 2001, Journal of Mammary Gland Biology and Neoplasia.

[38]  M M Weiss,et al.  Comparative genomic hybridisation. , 1999, Molecular pathology : MP.

[39]  M. Westerfield,et al.  Characterization of paired tumor and non‐tumor cell lines established from patients with breast cancer , 1998, International journal of cancer.

[40]  D. Pinkel,et al.  Comparative Genomic Hybridization for Molecular Cytogenetic Analysis of Solid Tumors , 2022 .

[41]  S. Dairkee,et al.  Immortalization in culture: occurrence at a late stage in the progression of breast cancer. , 1987, Journal of the National Cancer Institute.

[42]  E Y LASFARGUES,et al.  Cultivation of human breast carcinomas. , 1958, Journal of the National Cancer Institute.

[43]  Va Medical.  Breast cancer resistance protein(BCRP/ABCG2):its role in multidrug resistance and regulation of its gene expression , 2012 .

[44]  G. Dontu,et al.  Survival of Mammary Stem Cells in Suspension Culture: Implications for Stem Cell Biology and Neoplasia , 2005, Journal of Mammary Gland Biology and Neoplasia.

[45]  Carlos López-Otín,et al.  Matrix metalloproteinases and tumor progression. , 2003, Advances in experimental medicine and biology.

[46]  A. Leibovitz.  6 – Cell Lines from Human Breast , 1994 .

[47]  H. Smith,et al.  The biology of breast cancer at the cellular level. , 1984, Biochimica et biophysica acta.